Nicole Germino
Stock Analyst at Truist Securities
(3.97)
# 687
Out of 4,496 analysts
13
Total ratings
54.55%
Success rate
14.25%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $68 → $88 | $75.97 | +15.84% | 4 | Jul 1, 2024 | |
| YMAB Y-mAbs Therapeutics | Initiates: Buy | $21 | $11.59 | +81.19% | 1 | Jun 28, 2024 | |
| SGMO Sangamo Therapeutics | Downgrades: Hold | n/a | $0.40 | - | 4 | Nov 7, 2023 | |
| ASMB Assembly Biosciences | Downgrades: Hold | $132 → $24 | $15.13 | +58.63% | 3 | Oct 24, 2022 | |
| FBRX Forte Biosciences | Downgrades: Hold | n/a | $0.59 | - | 1 | Sep 3, 2021 |
Insmed
Jul 1, 2024
Maintains: Buy
Price Target: $68 → $88
Current: $75.97
Upside: +15.84%
Y-mAbs Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $21
Current: $11.59
Upside: +81.19%
Sangamo Therapeutics
Nov 7, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.40
Upside: -
Assembly Biosciences
Oct 24, 2022
Downgrades: Hold
Price Target: $132 → $24
Current: $15.13
Upside: +58.63%
Forte Biosciences
Sep 3, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.59
Upside: -